Furthermore, resveratrol inhibited the migration and invasion of prostate cancer cells by promoting demethylation and increasing the expression of tissue inhibitors of metalloproteinases, TIMP2, and TIMP3 and by suppressing the expression of MMP-2 and MMP-9 [26,27]. Here, TIMP2 is linked to prostate carcinoma.